Health condition
DLBCL guide
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma; it grows quickly but is curable in the majority of patients with prompt combination immunochemotherapy.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
An aggressive lymphoma needing treatment soon after diagnosis - it is not watch and wait
-
Standard first-line treatment is R-CHOP or the newer pola-R-CHP combination
-
Cure is the explicit goal of first-line therapy
-
Relapsed disease has effective options including CAR-T cell therapy
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
DLBCL usually presents as a rapidly enlarging lymph node mass, sometimes with drenching night sweats, fevers or weight loss, and can arise almost anywhere in the body. The pace of the disease means the pathway moves fast: biopsy, PET-CT staging, cardiac assessment and treatment ideally within weeks. Prognostic scores and molecular subtyping refine expectations but rarely delay the start.
Diagnosis and treatment routes
Six cycles of rituximab-based immunochemotherapy cure most patients; polatuzumab-based first-line treatment has edged outcomes further in higher-risk disease. Those who relapse early are now frequently offered CAR-T cell therapy - a genuinely transformative option - while later relapses may still be approached with transplant or newer antibodies. End-of-treatment PET defines remission, after which follow-up focuses on the first two years, when relapse risk is highest. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about DLBCL guide.
Quick, plain-English answers to what people ask us most.
-
What is DLBCL?
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma - a cancer of the lymphatic system - which grows quickly but is curable in the majority of patients with modern combination treatment.
-
What causes DLBCL?
The exact cause isn't fully understood in most cases, though risk factors can include a weakened immune system and certain viral infections, with most cases occurring without a clearly identifiable specific cause.
-
What are the symptoms of DLBCL?
Common symptoms include a rapidly enlarging lymph node, fatigue, unexplained weight loss, night sweats, and fever, though the specific pattern can vary depending on which areas of the body are involved.
-
Is DLBCL dangerous?
It's an aggressive cancer requiring prompt treatment, but importantly, it's one of the more curable aggressive lymphomas, with a significant majority of patients achieving long-term remission or cure with modern treatment.
-
How is DLBCL treated?
The standard treatment is R-CHOP, a combination of the antibody rituximab with chemotherapy drugs, given over several cycles, with treatment tailored to individual disease features and overall health.
-
How curable is DLBCL?
DLBCL is curable in the majority of patients with standard R-CHOP treatment, representing one of the notable treatment success stories among aggressive cancers, though outcomes do vary based on specific disease characteristics.
-
How long does DLBCL treatment take?
A standard course of chemotherapy treatment typically spans four to six months, with response assessed through imaging during and after the treatment course to confirm effectiveness.
-
What happens if DLBCL doesn't respond to initial treatment?
Options for relapsed or treatment-resistant DLBCL include different chemotherapy combinations, stem cell transplantation, or newer treatments such as CAR-T cell therapy, chosen based on individual circumstances and specialist assessment.
-
How is DLBCL diagnosed and staged?
Diagnosis requires a biopsy of an affected lymph node or tissue, followed by staging investigations (such as CT or PET scans) to determine the extent of disease, which guides the treatment plan and prognosis discussion.
-
When should I see a specialist about a rapidly enlarging lymph node?
See a doctor promptly for any rapidly enlarging or persistent lymph node, particularly with weight loss or night sweats, given the importance of prompt diagnosis and treatment for this fast-growing but generally curable cancer.